Regulatory UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention PharmaTimesClesrovimab is first monoclonal antibody offering a single fixed dose for infantsInfectious DiseaseRead full story pharminent April 27, 2026 (Last updated: April 27, 2026) PharmaTimes Clesrovimab is first monoclonal antibody offering a single fixed dose for infants Infectious Disease Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Sun Pharma to acquire Organon for $11.75bnNext: UK biotech could be bound for recovery, BIA report reveals Related Stories Regulatory FDA approves MSD’s Keytruda combinations for MIBC pharminent July 13, 2026 Regulatory FDA freezes CRL trove as ‘radical transparency’ push hits speedbump pharminent July 9, 2026 Regulatory UK first in Europe to clear Boehringer’s IPF drug Jascayd pharminent July 9, 2026
